Market Place
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most! 
X
Please Wait
Applying Filters...
01 Evonik Corporation (1)
01 Linzagolix Choline (1)
01 Germany (1)
78
PharmaCompass offers a list of Linzagolix API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Linzagolix manufacturer or Linzagolix supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linzagolix manufacturer or Linzagolix supplier.
PharmaCompass also assists you with knowing the Linzagolix API Price utilized in the formulation of products. Linzagolix API Price is not always fixed or binding as the Linzagolix Price is obtained through a variety of data sources. The Linzagolix Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Linzagolix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linzagolix, including repackagers and relabelers. The FDA regulates Linzagolix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linzagolix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Linzagolix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Linzagolix supplier is an individual or a company that provides Linzagolix active pharmaceutical ingredient (API) or Linzagolix finished formulations upon request. The Linzagolix suppliers may include Linzagolix API manufacturers, exporters, distributors and traders.
click here to find a list of Linzagolix suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Linzagolix as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Linzagolix API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Linzagolix as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Linzagolix and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Linzagolix NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Linzagolix suppliers with NDC on PharmaCompass.
